Stockreport

OS Therapies to Present at H.C. Wainright 26th Annual Global Investment Conference

OS Therapies Incorporated  (OSTX) 
PDF NEW YORK--(BUSINESS WIRE)--OS Therapies (NYSE American: OSTX) (“OS Therapies” or “the Company”), an ADC and Immunotherapy research and clinical-stage biopharmaceutic [Read more]